David J. Wambeke, Chief Business Officer at DiaMedica Therapeutics Inc. (DMAC), bought 468,750 shares at $1.60 ($750K) on 2023-04-10, disclosed to the SEC on 2023-04-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| DMAC | BUY | 2023-11-16 | $49K | — | Filing → |
| DMAC | BUY | 2023-06-26 | $300K | — | Filing → |